Alnylam and Precision partner to discover and develop small lipid nanoparticles using Precision's microfluidics technology

Precision NanoSystems Inc.

Canada / Medical Devices and Diagnostics

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Alnylam Pharmaceuticals Inc.

U.S. / Mid-Cap Biopharma ($1-$50 billion)

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced